Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

706 articles

Showing 1–7 of 7 articles · Keyword: Extracellular vesicles Clear keyword

Frontiers in immunology2026ReviewDrug Delivery

1. Extracellular vesicle-based drug delivery in pediatric immune thrombocytopenia

Di Domenico O, Marrapodi Mm, Di Feo G, Argenziano L, Rossi F, Di Paola A

Pediatric immune thrombocytopenia (ITP) is an acquired immune-mediated disorder triggered by autoantibody production directed against glycoproteins on the platelet surface, leading to platelet destruction in the spleen and impaired megakaryopoiesis in the bone marrow. The immune response is further compromised by a…

Read the article
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026ReviewDrug Delivery

2. Mesenchymal stem cell-derived exosomes as nanocarriers for curcumin: from fundamental research to clinical translation

Pan Y, Wang R, Qin S, Zhao L, Xing X

Curcumin has diverse pharmacological activities but poor water solubility, rapid degradation, extensive metabolism, and very low oral bioavailability limit its therapeutic use. This review evaluates mesenchymal stem cell-derived exosomes (MSC-Exo; MSC-derived small extracellular vesicles per MISEV2023) as natural…

Read the article
Molecules (Basel, Switzerland)2026ReviewDrug Delivery

3. Selecting Administration Routes for Therapeutic Extracellular Vesicles to Achieve Optimal Drug Delivery

Lee M, Choi Y, Yoon Sj, Kim M

Extracellular vesicles (EVs) have emerged as promising therapeutic carriers owing to their biocompatibility, low immunogenicity, and ability to transport diverse biological cargo. However, successful EV-based therapy depends not only on carrier engineering but also on selecting an administration route appropriate for…

Read the article
Frontiers in oncology2026ReviewDrug Delivery

4. Extracellular vesicles as biomimetic platforms for photo-assisted cancer therapy: evolution from synthetic nanocarriers to engineered therapeutic systems

Beaugé L, Ibarra Le

Photo-assisted therapies have emerged as promising strategies for cancer treatment by combining localized tumor ablation with the induction of systemic antitumor immune responses. Despite encouraging preclinical and clinical advances, their therapeutic efficacy remains limited by the unfavorable pharmacokinetics…

Read the article
Translational research : the journal of laboratory and clinical medicine2026ReviewDrug Delivery

5. Coupling Extracellular Vesicles with Nanomedicine for Precision Theranostics

Kausar T, Ahmed W, Shafiq T, Kausar R, Liang Y, Duan L

Nanomedicine represents one of the pivotal technologies that further bridges critical gaps in precision theranostics through targeted delivery, integrated diagnostics and therapeutics, and personalized treatment. Among various nanocarriers, extracellular vesicles (EVs) have attracted substantial interest owing to…

Read the article
International journal of nanomedicine2026ReviewDrug Delivery

6. Macrophage-Based Nanoplatforms for Tumor-Targeted Drug Delivery and Cancer Immunomodulation: Extracellular Vesicles, Membrane-Coated Nanoparticles, and Live Cells

Li X, Yu Y, Xie Y, He P, Chen Y, Guo Z, Et Al.

Macrophages are highly plastic immune cells with tumor-homing capacity and immunomodulatory functions, making macrophage-based nanoplatforms attractive for cancer immunotherapy. Macrophage-based nanoplatforms include macrophage-derived extracellular vesicles (EVs), macrophage membrane-coated nanoparticles, and live…

Read the article
International Journal of Pharmaceutics.2017ReviewNon-viral Gene Delivery

7. Targeted si-RNA with liposomes and exosomes (extracellular vesicles): How to unlock the potential

RNA interference (RNAi) therapeutics have shown potential for treating genetic, viral, and cancerous diseases, but the main bottleneck remains delivery of functional RNA molecules into the cell cytoplasm. The review focuses on liposomes and other lipid carriers, and on exosomes/extracellular vesicles (EVs), as…

Read the article
Articles | Brilliant Blue Biosciences